Fatskills
Practice. Master. Repeat.
Study Guide: AP Biology: Second Messengers (cAMP, Ca²?, IP3) and Phosphorylation Cascades
Source: https://www.fatskills.com/ap-biology/chapter/ap-biology-second-messengers-camp-ca%C2%B2-ip3-and-phosphorylation-cascades

AP Biology: Second Messengers (cAMP, Ca²?, IP3) and Phosphorylation Cascades

By Fatskills Exam Guides Team — the exam nerds behind 28,500+ quizzes and 2.1M practice questions across 500+ global exams.

⏱️ ~4 min read

Second Messengers (cAMP, Ca²?, IP3) and Phosphorylation Cascades

Concept Summary

  • Second messengers: Small, non-protein molecules (e.g., cAMP, Ca²?, IP?) that amplify extracellular signals intracellularly by relaying and amplifying signals from membrane receptors to downstream targets.
  • cAMP (cyclic AMP): A nucleotide derived from ATP that activates protein kinase A (PKA), initiating phosphorylation cascades; critical for glycogen breakdown and hormone responses.
  • Ca²? (calcium ions): A versatile second messenger stored in the ER/mitochondria, released via IP? or voltage-gated channels; regulates muscle contraction, neurotransmitter release, and enzyme activity.
  • IP? (inositol trisphosphate): A lipid-derived second messenger generated by phospholipase C (PLC) that binds ER receptors to release Ca²?, linking GPCR activation to intracellular Ca²? signaling.
  • Phosphorylation cascades: Sequential kinase-mediated phosphorylation of proteins (e.g., MAPK pathway) that amplify signals, regulate enzyme activity, and enable rapid cellular responses to stimuli.

Core Questions

WHAT (definitional)

Q: What is a second messenger? A: A small, diffusible molecule (e.g., cAMP, Ca²?, IP?) that transmits and amplifies signals from membrane receptors to intracellular targets. Trap/Clarification: Second messengers are not proteins (e.g., kinases) or extracellular ligands (e.g., hormones).

Q: What is a phosphorylation cascade? A: A series of kinase-mediated phosphorylation events where each kinase activates the next, amplifying a signal and regulating protein activity. Trap/Clarification: Cascades do not involve dephosphorylation (phosphatases terminate signals); they are unidirectional until phosphatases act.


WHY (causal/explanatory)

Q: Why is cAMP important in signal transduction? A: cAMP activates PKA, which phosphorylates multiple targets (e.g., enzymes, transcription factors), enabling rapid, amplified responses to hormones like epinephrine. Trap/Clarification: cAMP does not directly phosphorylate proteins—it binds PKA’s regulatory subunits to release catalytic subunits.

Q: Why is Ca²? a versatile second messenger? A: Ca²? binds calmodulin and other proteins, altering their conformation to regulate diverse processes (e.g., muscle contraction, exocytosis, apoptosis) with spatial/temporal precision. Trap/Clarification: Ca²? does not diffuse freely in the cytosol; its concentration is tightly controlled by pumps (e.g., SERCA) and buffers.


HOW (process/application)

Q: How is cAMP generated and degraded? A: Generation: Adenylyl cyclase (activated by G?s) converts ATP-cAMP. Degradation: Phosphodiesterase (PDE) hydrolyzes cAMP-AMP. Trap/Clarification: cAMP levels do not depend on ATP synthesis rates; they’re regulated by adenylyl cyclase/PDE balance.

Q: How does IP? trigger Ca²? release? A: IP? binds IP? receptors on the ER, opening Ca²? channels; released Ca²? can further activate PKC or calmodulin in a positive feedback loop. Trap/Clarification: IP? does not directly activate PKC—it releases Ca²?, which then binds PKC’s regulatory domain.

Q: How do phosphorylation cascades amplify signals? A: Each kinase phosphorylates multiple downstream targets (e.g., 1 kinase-10 kinases-100 targets), exponentially increasing the signal’s reach. Trap/Clarification: Amplification does not require new protein synthesis; it relies on pre-existing kinases and substrates.


CAN (conditions/possibilities)

Q: Can second messengers cross the plasma membrane? A: No; second messengers (e.g., cAMP, Ca²?, IP?) are intracellular molecules generated after ligand binding to membrane receptors. Trap/Clarification: Lipophilic hormones (e.g., steroids) do cross membranes but are not second messengers—they bind intracellular receptors.

Q: Under what conditions does Ca²? act as a second messenger? A: When its cytosolic concentration rises (e.g., via IP?-mediated ER release or voltage-gated channels), triggering responses like muscle contraction or vesicle fusion. Trap/Clarification: Basal Ca²? levels (~100 nM) are too low to activate targets; signaling requires transient spikes (?M range).


Quick Facts & Traps

  • Fact: cAMP is synthesized by adenylyl cyclase (activated by G?s) and degraded by phosphodiesterase (PDE); caffeine inhibits PDE, prolonging cAMP effects.
  • Trap: "cAMP directly phosphorylates proteins."-Reality: cAMP binds PKA’s regulatory subunits, releasing catalytic subunits to phosphorylate targets.
  • Fact: IP? and DAG are both products of PLC-mediated PIP? cleavage; IP? releases Ca²?, while DAG activates PKC (with Ca²?).
  • Trap: "Ca²? is only stored in the ER."-Reality: Mitochondria and extracellular space also store Ca²?, but ER release is the primary signaling source.
  • Fact: Phosphorylation cascades use serine/threonine kinases (e.g., PKA, MAPK) or tyrosine kinases (e.g., receptor TKs); phosphatases reverse phosphorylation.
  • Trap: "All kinases add phosphate groups to proteins."-Reality: Kinases transfer phosphates from ATP; they do not create phosphate groups de novo.

Rapid-Fire True/False

  • Statement: Second messengers like cAMP and Ca²? are proteins. Answer: FALSE Why the common mistake happens: Confusion with kinases/phosphatases (which are proteins); second messengers are small molecules/ions.

  • Statement: Phosphorylation cascades always increase protein activity. Answer: FALSE Why the common mistake happens: Overgeneralization—phosphorylation can activate (e.g., glycogen phosphorylase) or inhibit (e.g., glycogen synthase) targets.

  • Statement: IP? directly activates protein kinase C (PKC). Answer: FALSE Why the common mistake happens: IP? releases Ca²?, which then binds PKC’s regulatory domain; IP? itself does not interact with PKC.